Please provide your email address to receive an email when new articles are posted on . Compared with urine samples, vaginal swabs had significantly greater sensitivity for chlamydia and gonorrhea.

Add Yahoo as a preferred source to see more of our stories on Google. Doctors say that home tests can be as accurate as getting tested in a lab if you get a good sample. (Getty Images) (MMilda via ...

NEW YORK (Reuters Health) - A new 30-minute point-of-care (POC) test using self-collected vaginal swabs works as well as lab-based molecular diagnostic tests for detecting chlamydia and gonorrhea, new ...

Starting this week, women can order a first-of-its-kind, at-home swab test for chlamydia, gonorrhea and trichomoniasis and have it delivered straight to their door. Late-night cravings aren’t the only ...

Vaginal swab samples collected by patients performed similarly to lab-based molecular diagnostics for chlamydia and gonorrhea testing, therefore supporting the use of a new 30-minute point-of-case ...

Up until now, people concerned that they might have chlamydia or gonorrhea would have to get tested at a doctor’s office. Users of the new test won’t need a prescription and can activate it online.

In men, complications from chlamydia are relatively uncommon. When they do occur, resulting infections include urethritis, epididymitis, and in rare cases sterility or reactive arthritis. Infection ...

Liz Sturgiss receives funding from the NHMRC, MRFF, RACGP Foundation, Diabetes Australia and VicHealth that is unrelated to this article. She is affiliated with Australian Journal of Primary Health ...

Credit: Visby Medical. The approval was based on a clinical study that included 2203 females aged 14 years and older. The Food and Drug Administration (FDA) has cleared the Visby Medical Women’s ...

Chlamydia is often called a “silent infection” because many people don’t know they have it. It’s caused by a type of bacteria called Chlamydia trachomatis and can affect both men and women. While it’s ...

A new rapid test for chlamydia, the world's most common sexually transmitted infection, has proved successful in trials and could help rein in a worrying rise in the disease, British scientists said ...